Načítá se...
The role of adjuvant therapy in uterine leiomyosarcoma
Uterine leiomyosarcoma (uLMS) is a rare mesenchymal tumor of the gynecologic tract. Although diagnosed in only 1-3% of patients with uterine cancer, uLMS accounts for the majority of uterine cancer-related deaths. The standard of care for patients with uLMS includes total hysterectomy and bilateral...
Uloženo v:
| Vydáno v: | Expert Rev Anticancer Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836291/ https://ncbi.nlm.nih.gov/pubmed/26558647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2016.1115724 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|